Lv11
20 积分 2022-05-17 加入
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
5小时前
待确认
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
5小时前
已完结
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
6小时前
已完结
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
6小时前
已完结
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
6小时前
已完结
Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis
4天前
已完结
FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodies
14天前
已完结
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
14天前
已完结
Vunakizumab: First Approval
21天前
已完结
Vunakizumab: First Approval
21天前
已完结
皖公网安备34019202002308
